Dawid G. Nowak

Dawid G. Nowak

Auto-generated profile, based on publicly available information

Dawid G. Nowak

Weill Cornell Medicine

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2024 in Science
Verified
Journal Article
Closed access
MSManojit Mosur Swamynathan
Manojit Mosur Swamynathan
SKShan Kuang
Shan Kuang
KWKaitlin E. Watrud
Kaitlin E. Watrud
MDMary R. Doherty
Mary R. Doherty
CGCharlotte Gineste
Charlotte Gineste
LTLloyd C Trotman
Lloyd C Trotman
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] suppresses PC progression in mice, killing cells through an oxidative cell death: MSB antagonizes the essential class III phosphatidylinositol (PI) 3-kinase VPS34—the regulator of endosome identity and sorting—through oxidation of key cysteines, pointing to a redox checkpoint in sorting. Testing MSB in a myotubular myopathy model that is driven by loss of MTM1 —the phosphatase antagonist of VPS34—we show that dietary MSB improved muscle histology and function and extended life span. These findings enhance our understanding of pro-oxidant selectivity and show how definition of the pathways they impinge on can give rise to unexpected therapeutic opportunities.

5 July 2024 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
RSRyan N. Serio
Ryan N. Serio
ASArmin Scheben
Armin Scheben
BLBilly Lu
Billy Lu
DGDomenic V. Gargiulo
Domenic V. Gargiulo
LPLucrezia Patruno
Lucrezia Patruno
DNDawid G. Nowak
Dawid G. Nowak
The patterns by which primary tumors spread to metastatic sites remain poorly understood. Here, we define patterns of metastatic seeding in prostate cancer using a novel injection-based mouse model—EvoCaP (Evolution in Cancer of the Prostate), featuring aggressive metastatic cancer to bone, liver, lungs, and lymph nodes. To define migration histories between primary and metastatic sites, we used our EvoTraceR pipeline to track distinct tumor clones containing recordable barcodes. We detected widespread intratumoral heterogeneity from the primary tumor in metastatic seeding, with few clonal populations instigating most migration. Metastasis-to-metastasis seeding was uncommon, as most cells remained confined within the tissue. Migration patterns in our model were congruent with human prostate cancer seeding topologies. Our findings support the view of metastatic prostate cancer as a systemic disease driven by waves of aggressive clones expanding their niche, infrequently overcoming constraints that otherwise keep them confined in the primary or metastatic site. Significance: Defining the kinetics of prostate cancer metastasis is critical for developing novel therapeutic strategies. This study uses CRISPR/Cas9-based barcoding technology to accurately define tumor clonal patterns and routes of migration in a novel somatically engineered mouse model (EvoCaP) that recapitulates human prostate cancer using an in-house developed analytical pipeline (EvoTraceR).

12 September 2025 in bioRxiv
Verified
Preprint
Open access
SSStephen Staklinski
Stephen Staklinski
ASArmin Scheben
Armin Scheben
LBLise M Brault
Lise M Brault
RHRebecca Hassett
Rebecca Hassett
RSRyan N Serio
Ryan N Serio
ASAdam Siepel
Adam Siepel
Cell-lineage tracing now enables direct study of tissue migration in metastatic cancer, but current reconstruction algorithms are limited by a reliance on strong parsimony assumptions and pre-estimated cell-lineage phylogenies. Here, we introduce a probabilistic modeling and inference framework, called BEAM (Bayesian Evolutionary Analysis of Metastasis), that provides richer information about complex metastatic histories. Based on the flexible BEAST 2 platform for Bayesian phylogenetics, BEAM infers a full posterior distribution over cell-lineage phylogenies and tissue migration graphs, complete with timing information. We show using simulated data that BEAM reliably outperforms current methods for inference of tissue migration graphs, especially for more complex histories. We then apply BEAM to public data sets for lung and prostate cancer, finding support for distinct modes of migration across clones and reseeding of primary tumors. Overall, BEAM serves as a powerful framework for revealing the modes, timing, and directionality of tissue migration in metastatic cancer.

28 June 2026 in bioRxiv
Verified
Preprint
Open access
JXJiawei Xing
Jiawei Xing
SSStephen Staklinski
Stephen Staklinski
ZLZhihan Liu
Zhihan Liu
DNDawid Nowak
Dawid Nowak
ASAdam Siepel
Adam Siepel
Gene expression evolves dynamically along cell lineages, yet most analysis methods treat single-cell RNA-seq (scRNA-seq) data as static snapshots and fail to exploit phylogenetic relationships among cells. Recent advances in cell-lineage tracing now enable the reconstruction of high-resolution lineage phylogenies, providing a natural framework for identifying when and where transcriptional changes arise during development, differentiation, and disease progression. Some models of gene expression have begun to consider phylogenetic structure, but they generally rely on imprecise Gaussian assumptions, focus on endpoint-level comparisons, or fail to consider sparse and overdispersed scRNA-seq read counts. Here, we present LaVOUS (Lineage-aware Variational Ornstein-Uhlenbeck Single-cell RNA-seq analysis), a probabilistic framework that couples lineage-based models of latent dynamics derived from the Brownian motion and Ornstein-Uhlenbeck stochastic processes with negative-binomial observation models and scalable variational inference. LaVOUS enables likelihood-based tests for cellular heritability and branch-specific shifts in gene expression, as well as phylogenetic reconstruction of latent expression histories. In simulations, LaVOUS outperformed Gaussian method in detecting lineage-associated expression changes and produced accurate reconstructions of expression histories across expression levels. We additionally applied LaVOUS to paired single-cell lineage and transcriptomic data from metastatic lung cancer, class-switching B cells, and the developing brain. Across these settings, LaVOUS identified lineage-associated expression changes related to metastatic progression, B-cell isotype switching, and dopaminergic and glutamatergic neuron differentiation. By providing an expressive framework for modeling sparse count data on lineage trees, LaVOUS establishes a foundation for studying single-cell expression dynamics across developmental and disease contexts, with natural extensions to multi-gene regulation, lineage uncertainty, and multi-modal integration.

17 June 2026
Verified
Other
Open access
RSRyan N. Serio
Ryan N. Serio
ASArmin Scheben
Armin Scheben
BLBilly Lu
Billy Lu
DGDomenic V. Gargiulo
Domenic V. Gargiulo
LPLucrezia Patruno
Lucrezia Patruno
DNDawid G. Nowak
Dawid G. Nowak
Supplementary Figure S5. Immunostaining of tissues excised from prostate tumor regions.

17 June 2026
Verified
Other
Open access
RSRyan N. Serio
Ryan N. Serio
ASArmin Scheben
Armin Scheben
BLBilly Lu
Billy Lu
DGDomenic V. Gargiulo
Domenic V. Gargiulo
LPLucrezia Patruno
Lucrezia Patruno
DNDawid G. Nowak
Dawid G. Nowak
Supplementary Figure S1. Validation of EvoCaP platform in vitro. Supplementary Figure S2. BC10 exhibited robust editing efficiency in vitro. Supplementary Figure S3. Technical markers to identify tumor cells are present in organs. Supplementary Figure S4. Consistent bioluminescence and fluorescence imaging of tissues from EvoCaP mice.